ClinicalTrials.Veeva

Menu

Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients

Rigshospitalet logo

Rigshospitalet

Status

Terminated

Conditions

Renal Insufficiency, Chronic

Treatments

Drug: Mepivacaine with epinephrine
Drug: Plain mepivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT01533545
H-3-2011-154
2012-000948-98 (EudraCT Number)

Details and patient eligibility

About

The aim of this study is to determine the effect of epinephrine on systemic absorption of local anaesthetic mepivacaine administered for brachial plexus block in uremic patients scheduled for creation or repair of an arteriovenous fistula. Furthermore, an impact of epinephrine on the central circulation and peripheral tissue oxygenation will be evaluated.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient acceptance of regional anaesthesia

Exclusion criteria

  • peripheral arteriosclerosis
  • diabetes mellitus
  • bleeding disorder
  • infection at the puncture site
  • allergy to mepivacaine
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

16 participants in 2 patient groups

Plain mepivacaine
Active Comparator group
Treatment:
Drug: Plain mepivacaine
Mepivacaine with epinephrine
Active Comparator group
Treatment:
Drug: Mepivacaine with epinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems